SEC Form 4 · accession 0001179110-17-007452
DAVITA INC. · DVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Javier Rodriguez
Officer — CEO-Kidney Care
Period of report
May 15, 2017
Accepted (ET)
May 17, 2017 · 6:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000927066
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 15, 2017 | A | 1,294 | $0.00 | A | 99,111 | D | |
| Common StockF1 | May 15, 2017 | S | 1,294 | $66.2058 | D | 97,817 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average sale price of $65.2058. The range of prices for the sale of these shares was $66.1300 - $66.2550 rounded to the nearest ten-thousandths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.